- Report
- February 2024
- 245 Pages
Global
From €6908EUR$7,950USD£6,022GBP
- Report
- January 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,401GBP
- Report
- August 2025
- 70 Pages
India
From €3041EUR$3,500USD£2,651GBP
- Report
- April 2023
- 115 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- November 2024
- 67 Pages
From €2998EUR$3,450USD£2,613GBP
- Report
- January 2025
- 186 Pages
Global
From €4340EUR$4,995USD£3,784GBP
- Report
- June 2022
- 242 Pages
Global
From €3128EUR$3,600USD£2,727GBP
- Report
- October 2025
- 87 Pages
Japan
From €4214EUR$4,850USD£3,674GBP
- Book
- November 2024
North America
- Book
- April 2023
North America
- Book
- June 2022
North America
- Book
- April 2021
North America
- Book
- March 2019
North America
- Book
- December 2018
North America
- Book
- November 2016
North America

The Cancer Management market within the context of Oncology is a rapidly growing sector of the healthcare industry. It encompasses a wide range of services, products, and technologies that are used to diagnose, treat, and manage cancer. This includes treatments such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy, as well as diagnostic tests, imaging, and other supportive care services. The market also includes a variety of products and services related to cancer prevention, such as screening tests, lifestyle modifications, and genetic testing.
The Cancer Management market is driven by advances in technology, increasing prevalence of cancer, and the growing demand for personalized treatments. Additionally, the increasing availability of healthcare services and the rising awareness of cancer among the general population are also contributing to the growth of the market.
Some of the major companies in the Cancer Management market include Roche, Novartis, Merck, Pfizer, Bristol-Myers Squibb, AstraZeneca, and Johnson & Johnson. Show Less Read more